This company is no longer active
A217600 Stock Overview
ChemOn Inc. provides various analytical, toxicity, and efficacy tests in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ChemOn Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,170.00 |
| 52 Week High | ₩4,400.00 |
| 52 Week Low | ₩1,890.00 |
| Beta | 0 |
| 1 Month Change | -8.25% |
| 3 Month Change | -9.77% |
| 1 Year Change | -29.55% |
| 3 Year Change | 55.56% |
| 5 Year Change | 46.62% |
| Change since IPO | -6.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| A217600 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | -2.4% |
| 1Y | -29.5% | 1.4% | 1.9% |
Return vs Industry: A217600 underperformed the KR Life Sciences industry which returned -16% over the past year.
Return vs Market: A217600 underperformed the KR Market which returned -23.1% over the past year.
Price Volatility
| A217600 volatility | |
|---|---|
| A217600 Average Weekly Movement | 11.1% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A217600 has not had significant price volatility in the past 3 months.
Volatility Over Time: A217600's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Si-Hwan Song | www.chemon.co.kr |
ChemOn Inc. provides various analytical, toxicity, and efficacy tests in South Korea. It offers tests in the areas of general, genetic, reproductive, and immuno toxicology; carcinogenicity/tumorigenicity; local irritation; pharmacology, anti-cancer, metabolism, digestion systems, immunity, nerve systems, menopausal disorders, pollutants eliminators, internal organs, beauty and health, and others; and pharmacokinetics, pharmacodynamics, toxicokinetics, bioequivalence, and ADME. The company also provides services, such as toxicity test with primates and in vitro pharmacology.
ChemOn Inc. Fundamentals Summary
| A217600 fundamental statistics | |
|---|---|
| Market cap | ₩138.58b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A217600 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A217600 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A217600 perform over the long term?
See historical performance and comparison